Feature Channels: Blood

Filters close
Released: 8-Sep-2022 11:10 AM EDT
How can you explain the pain? Get the latest research on pain management in the Pain channel
Newswise

The latest research and expert commentary on pain management.

Released: 7-Sep-2022 1:20 PM EDT
Elevated Cholesterol Found in GenX Exposure Study Participants
North Carolina State University

Elevated levels of per- and polyfluoroalkyl substances (PFAS) were associated with higher total cholesterol and non-HDL cholesterol in GenX Exposure Study participants’ blood. The effects were more pronounced in older people.

Newswise: New Chief of Blood Disorders Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 7-Sep-2022 8:00 AM EDT
New Chief of Blood Disorders Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Matthew Matasar, MD, MS, as Chief of Blood Disorders at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute. In this role, he will oversee the Sections of Hematologic Malignancies; Transplant and Cell Therapy; and Benign Hematology.

Newswise: Can a Person with Sickle Cell Disease Live a Normal Life?
Released: 6-Sep-2022 3:35 PM EDT
Can a Person with Sickle Cell Disease Live a Normal Life?
Rutgers Cancer Institute of New Jersey

People who have sickle cell disease (SCD), a genetic disorder that affects red blood cells, have reduced life expectancy and may face many challenges in their life. However, there are steps they can take to live the healthiest life possible despite this disease.

Newswise:Video Embedded ochsner-health-expert-available-to-comment-on-multiple-myeloma
VIDEO
Released: 1-Sep-2022 11:05 AM EDT
Ochsner Health expert available to comment on Multiple Myeloma
Ochsner Health

Ochsner Health hematologist oncologist, Dr. Andy Dalovisio is available to comment on Multiple Myeloma and other forms of blood cancer.

Newswise: Simple blood test predicts neurotoxic complications of CAR-T cell therapy
31-Aug-2022 3:05 PM EDT
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects in the days and weeks after CAR-T cell therapy.

Released: 1-Sep-2022 9:55 AM EDT
Mount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma Patients
Mount Sinai Health System

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time—they are meant to enhance the immune system’s destruction of tumor cells.

Newswise: Patient Education and Feedback to Nurses Help Improve Administration Of Clot-Busting Drugs
Released: 1-Sep-2022 9:50 AM EDT
Patient Education and Feedback to Nurses Help Improve Administration Of Clot-Busting Drugs
Johns Hopkins Medicine

Johns Hopkins Medicine study suggests strategies may prevent dangerous post-surgery condition

Newswise: August Research Highlights
Released: 31-Aug-2022 7:05 PM EDT
August Research Highlights
Cedars-Sinai

A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai

25-Aug-2022 3:55 PM EDT
Is Your Blood Type Linked to Your Risk of Stroke Before Age 60?
American Academy of Neurology (AAN)

Gene variants associated with a person’s blood type may be linked to their risk of early stroke, according to a new meta-analysis published in the August 31, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The meta-analysis included all available data from genetic studies that included young adult ischemic stroke, which is caused by a blockage of blood flow to the brain.

Newswise: SAFER Ukraine provides a blueprint for responding to global health crises
Released: 31-Aug-2022 12:00 PM EDT
SAFER Ukraine provides a blueprint for responding to global health crises
St. Jude Children's Research Hospital

Russia’s invasion of Ukraine created a dire situation for children with cancer and blood disorders. In response, the St. Jude Global initiative of St. Jude Children’s Research Hospital banded together with international partners and formed SAFER Ukraine. An account appears in The Lancet Haematology.

Newswise: Advancing new technologies to halt bleeding
Released: 30-Aug-2022 3:00 PM EDT
Advancing new technologies to halt bleeding
Case Western Reserve University

The research arm of the U. S. Army has awarded Case Western Reserve University blood surrogate pioneer Anirban Sen Gupta a four-year, $2.5 million grant to advance and optimize his latest nanotechnology to stop bleeding from battlefield injuries. The new technology devised by Sen Gupta and his team is called “SanguiStop.” It allows a clot-promoting enzyme called thrombin to be intravenously delivered in a targeted manner to a bleeding area—especially to the site of internal injuries.

Newswise: Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Released: 30-Aug-2022 1:05 PM EDT
Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Cedars-Sinai

Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer—at an early enough stage that cure is possible. Their work was published online in the peer-reviewed journal Hepatology.

Released: 29-Aug-2022 3:05 PM EDT
Full-dose anticoagulation treatment prevented blood clots in COVID-19 patients
Brigham and Women’s Hospital

A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women’s Hospital and the Critical Care Cardiology Trials Network (CCCTN) has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.

Released: 22-Aug-2022 3:45 PM EDT
Find expert commentary on the monkeypox outbreak here
Newswise

The latest research and expert commentary on the monkeypox outbreak.

Newswise: Could Blood Marker Predict the Risk of Osteoporotic Hip Fracture in Men?
Released: 17-Aug-2022 1:00 PM EDT
Could Blood Marker Predict the Risk of Osteoporotic Hip Fracture in Men?
Wiley

Bone health requires a balanced activity of various bone cell types including bone-forming osteoblasts and bone-resorbing osteoclasts. Osteoporosis occurs when osteoclasts dominate without adequate bone formation to compensate.

Newswise: Cell Mapping Close to the Bone
Released: 16-Aug-2022 4:05 PM EDT
Cell Mapping Close to the Bone
King Abdullah University of Science & Technology (KAUST)

Tissues contain many different cell types, and it remains challenging to understand how they interact and contribute to tissue function.

9-Aug-2022 2:05 PM EDT
The AABB releases clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma
American College of Physicians (ACP)

The Association for the Advancement of Blood and Biotherapies (AABB) has released clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma (CCP) in hospital and outpatient settings. Based on two living systematic reviews of randomized controlled trials (RCTs), the guidelines provide five specific recommendations for treating patients with COVID-19 and suggest that CCP is most effective when transfused with high neutralizing titers to infected patients early after symptom onset. The guidelines are published in Annals of Internal Medicine.

Released: 15-Aug-2022 8:05 AM EDT
Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT
Avails Medical, Inc.

Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.

Newswise: KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
Released: 12-Aug-2022 9:30 AM EDT
KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
University of Kansas Cancer Center

Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.

Newswise: Where do clots begin? McMaster researchers create device to replicate conditions in blood vessels after grafts
Released: 11-Aug-2022 11:30 AM EDT
Where do clots begin? McMaster researchers create device to replicate conditions in blood vessels after grafts
McMaster University

McMaster researchers create device to replicate conditions in blood vessels after grafts

Newswise: Experimental Drug Reduces Risk of Death From Blood Vessel Rupture in Mice
Released: 9-Aug-2022 6:05 PM EDT
Experimental Drug Reduces Risk of Death From Blood Vessel Rupture in Mice
Washington University in St. Louis

Nanoparticles (red) are taken up by immune cells (green with blue nuclei). Researchers at Washington University School of Medicine in St. Louis have shown that an experimental nanoparticle-based drug therapy protects mice from sudden death due to the rupture of a major blood vessel in the abdomen, pointing the way toward a new strategy for treating deadly abdominal aortic aneurysms.

Released: 9-Aug-2022 4:05 PM EDT
Vasculitis Foundation, International Organization for Vasculitis Community, Responding to the News of Ashton Kutcher’s Diagnosis of Vasculitis
Vasculitis Foundation

The Vasculitis Foundation applauds Ashton Kutcher for publicly sharing his diagnosis of vasculitis.

   
Newswise: See-through zebrafish, new imaging method put blood stem cells in high-resolution spotlight
Released: 9-Aug-2022 4:05 PM EDT
See-through zebrafish, new imaging method put blood stem cells in high-resolution spotlight
University of Wisconsin–Madison

MADISON — For the first time, researchers can get a high-resolution view of single blood stem cells thanks to a little help from microscopy and zebrafish.Researchers at the University of Wisconsin–Madison and the University of California San Diego have developed a method for scientists to track a single blood stem cell in a live organism and then describe the ultrastructure, or architecture, of that same cell using electron microscopy.

Released: 4-Aug-2022 12:25 PM EDT
YourBio Health: Partner in the Decentralization of Clinical Trials
YourBio Health

YourBio Health, Inc., developers of the world's first painless push-button blood collection device, was identified as a key contributor in the recent preprint published report in medRxiv.

2-Aug-2022 8:30 AM EDT
SuPAR identifies patients at high risk of blood clot formation
Michigan Medicine - University of Michigan

Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms—blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.

Released: 3-Aug-2022 3:35 PM EDT
Vitamin K prevents cell death: a new function for a long-known molecule
University of Ottawa

Vitamin K is well-known for its blood clotting and bone building properties but today a new study published in Nature reports on a novel function for vitamin K.

Released: 1-Aug-2022 4:05 PM EDT
心脏、脑部和腿部的外周动脉疾病可能预示着心血管问题
Mayo Clinic

或许您从未听说过外周动脉疾病,事实上,很多人都未听说过。尽管广大医生和卫生机构同心协力,让人们逐渐认识到了心脏病是全球头号致死原因,但作为心血管疾病之一的外周动脉疾病却仍未被大众所熟知。

Released: 1-Aug-2022 4:05 PM EDT
Enfermedad de las arterias periféricas señala problemas cardiovasculares en corazón, cerebro y piernas
Mayo Clinic

Si no ha escuchado hablar sobre la enfermedad de las arterias periféricas, no es la única persona que no lo ha hecho. Aunque los médicos y las organizaciones de atención de la salud han concienciado mejor acerca de que la enfermedad cardíaca es la primera causa de muerte en todo el mundo,

Released: 1-Aug-2022 4:05 PM EDT
A doença arterial periférica pode ser um sinal de problema cardiovascular no coração, cérebro e pernas
Mayo Clinic

Se você nunca ouviu falar da doença arterial periférica, você não está sozinho. Apesar de s médicos e as organizações de saúde já terem avançado na conscientização de que a doença cardíaca é a principal causa de morte em todo o mundo, a doença arterial periférica, mesmo sendo parte das doenças cardíacas, não é muito conhecida.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Released: 27-Jul-2022 5:30 PM EDT
KSL Beutner Laboratories Launches First Blood Test for Chronic, Debilitating Autoimmune Disease
2022 AACC Annual Scientific Meeting Press Program

KSL Beutner Laboratories (Beutner), a global leader in immunologic testing for the diagnosis of bullous, vascular, connective tissue and inherited skin diseases, has launched a first-to-market indirect immunofluorescence (IIF) serum blood test in the U.S. that positively identifies laminin 332, an antigen associated with the chronic, debilitating autoimmune disease mucous membrane pemphigoid (MMP).

Released: 27-Jul-2022 4:30 PM EDT
Ortho Ranks No.1 in Customer Satisfaction for 5 Years in a Row
2022 AACC Annual Scientific Meeting Press Program

QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho's customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments. The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho's innovative Ortho Care® Services and Informatics platform.

Released: 27-Jul-2022 2:25 PM EDT
Gaps in Representation of Women and Younger Scholars Among Medical Educators
American Society of Hematology (ASH)

Women make up just 37.7% of all speakers at hematology and medical oncology board review lectures, according to a study published today in Blood Advances.

Released: 27-Jul-2022 12:00 PM EDT
MD Anderson Research Highlights for July 27, 2022
University of Texas MD Anderson Cancer Center

Clinical advances include treating hematologic cancers with effective targeted therapies, circulating tumor DNA as a biomarker for recurrence with colorectal liver metastases, and using magnetic resonance imaging (MRI) to guide surgical decisions for patients with lateral pelvic lymph node metastases in rectal cancer. Laboratory findings offer new understanding of the pancreatic cancer immune microenvironment, melanoma cell states, TP53 mutation status in acute myeloid leukemia (AML), and potential targets for metastatic prostate cancer and GNAS-mutant colorectal cancer.

Newswise:Video Embedded cellavision-launches-a-complete-workflow-solution-for-low-volume-hematology-laboratories
VIDEO
Released: 27-Jul-2022 11:00 AM EDT
CellaVision launches a complete workflow solution for low-volume hematology laboratories
2022 AACC Annual Scientific Meeting Press Program

DIFF-Line™ by CellaVision is a new, comprehensive solution for small labs. It consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision® DC-1, RAL® SmearBox, and RAL® StainBox.

Newswise: Case Western Reserve-led study identifies way to specifically target and block disease-associated white blood cells
Released: 26-Jul-2022 2:05 PM EDT
Case Western Reserve-led study identifies way to specifically target and block disease-associated white blood cells
Case Western Reserve University

Neutrophils are a type of white blood cell that helps fight illness and disease by traveling to the body’s infected site to seek and destroy harmful pathogens.

Newswise:Video Embedded tesi-and-gpi-join-forces-for-the-first-time-at-american-association-for-clinical-chemistry-annual-meeting-in-chicago
VIDEO
Released: 26-Jul-2022 2:05 PM EDT
Tesi and GPI Join Forces for the First Time at American Association for Clinical Chemistry Annual Meeting in Chicago
2022 AACC Annual Scientific Meeting Press Program

Tesi Group will exhibit at the AACC Annual Scientific Meeting & Clinical Lab Expo alongside GPI USA, joined by Italian parent company Gpi Group, following up on an agreement recently signed by the two parties for the acquisition at the end of Q3 of 65% of the share capital of TESI by Gpi Group.

22-Jul-2022 1:05 PM EDT
Arlington Scientific, Inc. introduces a NEW intelligent rack loading system for the ASI Evolution Automated RPR Syphilis Analyzer
2022 AACC Annual Scientific Meeting Press Program

Arlington Scientific announces the introduction of a new sample rack loading system for the ASI Evolution Automated RPR Syphilis Analyzer.

Released: 26-Jul-2022 10:45 AM EDT
A Shortage with a Silver Lining: A Chance to Reduce Unneeded Blood Tests
Michigan Medicine - University of Michigan

A pandemic-related shortage of a mundane item – tubes to collect blood samples from patients -- has caused headaches for health systems worldwide. But it may also have a silver lining: A lesson in how to reduce unneeded medical tests, whether or not there’s a shortage, according to a new study.

Newswise: Stanford Cancer Team Halts Growth of Multiple Myeloma and Diffuse Large B Cell Lymphoma in Mice with Custom Molecule sBCMA-Fc V3
20-Jul-2022 10:35 AM EDT
Stanford Cancer Team Halts Growth of Multiple Myeloma and Diffuse Large B Cell Lymphoma in Mice with Custom Molecule sBCMA-Fc V3
The Rockefeller University Press

Researchers at Stanford University have developed “decoy receptor” molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to be published July 26 in the Journal of Experimental Medicine (JEM), were also found to be nontoxic in monkeys, suggesting they could be used to treat humans with either of these deadly diseases, which are two of the most common blood cancers around the world.

Newswise: Rhinostics Launches the VERIstic™ to Redefine Small Volume Blood Collection
Released: 24-Jul-2022 10:00 AM EDT
Rhinostics Launches the VERIstic™ to Redefine Small Volume Blood Collection
2022 AACC Annual Scientific Meeting Press Program

Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focused on small volume blood collection.

Released: 22-Jul-2022 1:45 PM EDT
DiaSorin Receives FDA 510(K) Clearance for Its LIAISON® MeMed BV® Test the First High Throughput Blood Test to Differentiate Between Bacterial and Viral Infections
2022 AACC Annual Scientific Meeting Press Program

DiaSorin (FTSE MIB: DIA) announced today the FDA 510(k) clearance and the commercial launch in the US of the host-protein signature-based assay LIAISON® MeMed BV®

Newswise: AI Speeds Sepsis Detection to Prevent Hundreds of Deaths
18-Jul-2022 11:05 AM EDT
AI Speeds Sepsis Detection to Prevent Hundreds of Deaths
 Johns Hopkins University

Patients are 20% less likely to die of sepsis because a new AI system developed at Johns Hopkins University catches symptoms hours earlier than traditional methods, an extensive hospital study demonstrates. The system, created by a Johns Hopkins researcher whose young nephew died from sepsis, scours medical records and clinical notes to identify patients at risk of life-threatening complications. The work, which could significantly cut patient mortality from one of the top causes of hospital deaths worldwide, is published today in Nature Medicine and Nature Digital Medicine.

Released: 20-Jul-2022 10:05 PM EDT
Genrui 5-Diff Hematology Analyzer KT-8000--SIMPLY MORE EFFICIENT
2022 AACC Annual Scientific Meeting Press Program

KT-8000 is equipped with auto-loader and sample mixer. This brand new fully automated hematology analyzer can free your hands and extend walk-away time. Smart counting mode can fit into more application scenarios than other hematology analyzers. Support both open vial/auto loading mode, and emergency sample first, and fit all the demands. Powerful data management unit has improved the work efficiency markedly.

Newswise: Sysmex America to Exhibit at AACC 2022: Sysmex Showcase Online and Live at Booth #2802
Released: 20-Jul-2022 1:25 PM EDT
Sysmex America to Exhibit at AACC 2022: Sysmex Showcase Online and Live at Booth #2802
2022 AACC Annual Scientific Meeting Press Program

Sysmex America products on display throughout the Expo at Booth #2802 in Chicago; Product Demonstrations and Educational Opportunities throughout the Show

Released: 19-Jul-2022 10:20 AM EDT
Black Adults Treated for Common Arterial Disease Are at Greater Risk of Amputation and Death Than White Adults, Researchers Show
Beth Israel Lahey Health

In this study, researchers at Beth Israel Deaconess Medical Center found that Black adults underwent significantly more endovascular peripheral vascular interventions (PVI), were treated for more advanced disease and were also more likely to experience adverse outcomes following PVI procedures, including amputation and death.  

Newswise: Training Blood Vessels May Help Protect Against Heart Attack, Stroke
Released: 19-Jul-2022 10:05 AM EDT
Training Blood Vessels May Help Protect Against Heart Attack, Stroke
Iowa State University

A growing number of studies indicate short, repeated bouts of reduced circulation with a blood pressure cuff may help reduce tissue damage and prevent the worst outcomes of heart attacks and strokes.



close
1.98351